Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.
about
Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cellsAP-2alpha Inhibits c-MYC Induced Oxidative Stress and Apoptosis in HaCaT Human KeratinocytesAP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cellsInterference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cellsSOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer.ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cellsAberrant expressions of AP-2α splice variants in pancreatic cancerReversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.The ERBB3 receptor in cancer and cancer gene therapyKAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells.A genetic cell context-dependent role for ZEB1 in lung cancer.Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha.Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q21260382-6360CE9B-A412-4DF0-A3F3-F2C98FB7AE90Q24294722-FC1FBF13-0AAB-4AEC-8605-0A613603FC67Q24676129-AB8EC074-92DF-471E-85E6-7FBCA9600969Q33575481-7A088D77-AC21-4EAB-A229-6AAD529AEF39Q33932242-9DEFA48A-106A-4BA2-90DD-E2E47F75140EQ34637108-19B2EC94-71EC-4342-ACF0-73F0567F003DQ35049500-63B93EE8-6E00-46F5-92EE-8CA078377AA0Q35562908-E7D8BDEE-531A-420E-9A09-6E541AAD507AQ35857669-DBDA14DB-0B8D-4D2C-849A-69E6DBE38D37Q36748207-319144AF-A261-4B5C-9DF6-4F8180C064F0Q37044197-BFD7616F-B6FC-46BE-A260-A8C78421DFB9Q37135372-B3215421-16A0-49A6-82AD-E2A8E2FD8CD8Q40484635-C930C08E-0C1A-4873-83B7-B2E76F2D4278Q41965882-E13BECAC-D4FC-4842-B53C-C32FA52E3195Q42399000-85AA7B2C-9382-4E24-88C0-9E8779E34D76Q47597474-BC6038CA-7C03-4E2C-8E81-04F4C7F3830FQ58803127-10AB15AB-35DE-405C-8E10-5819BE864AFB
P2860
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Dominant negative interference ...... presses malignant cell growth.
@en
type
label
Dominant negative interference ...... presses malignant cell growth.
@en
prefLabel
Dominant negative interference ...... presses malignant cell growth.
@en
P2860
P356
P1476
Dominant negative interference ...... presses malignant cell growth.
@en
P2093
Chun-Hong Zhu
P2860
P2888
P356
10.1023/A:1013378113916
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1016459134